
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SerpinA6 CRISPR/Cas9 KO Plasmid (h) | sc-407031 | 20 µg | $397.00 |
SERPINA6 encodes SerpinA6, also known as corticosteroid-binding globulin, a secreted serine protease inhibitor family member that primarily regulates systemic glucocorticoid bioavailability by binding and transporting cortisol in plasma. By buffering free cortisol levels, SerpinA6 influences glucocorticoid receptor signaling and downstream transcriptional programs that shape metabolism, immune responses, and stress physiology. Altered SERPINA6 expression or genetic variation has been associated with dysregulated hypothalamic–pituitary–adrenal axis activity and cortisol-related phenotypes, including susceptibility to metabolic and inflammatory traits. In experimental systems, SERPINA6 provides a handle to dissect endocrine signaling crosstalk with hepatic secretory pathways and extracellular protein homeostasis.
SerpinA6 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SERPINA6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SERPINA6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SERPINA6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SerpinA6 protein expression.
This CRISPR knockout system enables efficient generation of SERPINA6-deficient cell models for investigation of SerpinA6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.